NattoPharma is a world-leading vitamin K2 research and commercialization company. NattoPharma sells and develops MenaQ7® Vitamin K2 as MK-7, the most effective form of K2. We invest heavily in in-vitro, in-vivo, and clinical studies to document the effects of MenaQ7®, and hold an exclusive R&D alliance with VitaK BV, an expert in the research and scientific documentation of K vitamins. This commitment has created a patented and clinically validated K2 on the market. NattoPharma USA Inc. is a wholly-owned subsidiary of NattoPharma ASA, Norway, a publicly traded company.
328 Amboy Ave., Ste. D
Contact: Eric Anderson